Charlie A Elliot
Overview
Explore the profile of Charlie A Elliot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cerrone E, Hameed A, Kiely D, Condliffe R, Swift A, Rajaram S, et al.
Ann Am Thorac Soc
. 2024 Oct;
22(3):331-338.
PMID: 39405159
Chronic thromboembolic pulmonary disease (CTEPD) is defined by chronic organized thrombi in the pulmonary circulation without or with pulmonary hypertension. The current definition of chronic thromboembolic pulmonary hypertension (CTEPH) has...
2.
Smith H, Thompson A, Akil M, Alabed S, Charalampopoulos A, Dwivedi K, et al.
J Heart Lung Transplant
. 2024 Sep;
43(10):1629-1639.
PMID: 39260921
Background: There are limited data assessing the spectrum of systemic sclerosis-associated pulmonary hypertension (PH). Methods: Data for 912 systemic sclerosis patients assessed between 2000 and 2020 were retrieved from the...
3.
Durrington C, Hurdman J, Elliot C, Maclean R, Van Veen J, Saccullo G, et al.
Eur Respir J
. 2024 Feb;
63(3).
PMID: 38302154
Background: Diagnostic rates and risk factors for the subsequent development of chronic thromboembolic pulmonary hypertension (CTEPH) following pulmonary embolism (PE) are not well defined. Methods: Over a 10-year period (2010-2020),...
4.
Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K, et al.
Eur Respir J
. 2023 Jul;
62(2).
PMID: 37414419
Background: Cardiac magnetic resonance (CMR) is the gold standard technique to assess biventricular volumes and function, and is increasingly being considered as an end-point in clinical studies. Currently, with the...
5.
Hoeper M, Dwivedi K, Pausch C, Lewis R, Olsson K, Huscher D, et al.
Lancet Respir Med
. 2022 Jul;
10(10):937-948.
PMID: 35777416
Background: Among patients meeting diagnostic criteria for idiopathic pulmonary arterial hypertension (IPAH), there is an emerging lung phenotype characterised by a low diffusion capacity for carbon monoxide (DLCO) and a...
6.
Alandejani F, Hameed A, Tubman E, Alabed S, Shahin Y, Lewis R, et al.
Front Cardiovasc Med
. 2022 Apr;
9:797561.
PMID: 35402574
Background: Current European Society of Cardiology and European Respiratory Society guidelines recommend regular risk stratification with an aim of treating patients with pulmonary arterial hypertension (PAH) to improve or maintain...
7.
Shahin Y, Alabed S, Quadery S, Lewis R, Johns C, Alkhanfar D, et al.
Front Med (Lausanne)
. 2022 Apr;
9:840196.
PMID: 35360708
Providing prognostic information is important when counseling patients and planning treatment strategies in chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to assess the prognostic value of...
8.
Garg P, Lewis R, Johns C, Swift A, Capener D, Rajaram S, et al.
Int J Cardiovasc Imaging
. 2021 May;
37(10):3019-3025.
PMID: 33978936
This study aimed to determine the prognostic value of cardiovascular magnetic resonance (CMR) in patients with heart failure with preserved ejection fraction and associated pulmonary hypertension (pulmonary hypertension-HFpEF). Patients with...
9.
Bauchmuller K, Condliffe R, Southern J, Billings C, Charalampopoulos A, Elliot C, et al.
ERJ Open Res
. 2021 Apr;
7(2).
PMID: 33834051
Pulmonary hypertension (PH) is a life-shortening condition characterised by episodes of decompensation precipitated by factors such as disease progression, arrhythmias and sepsis. Surgery and pregnancy also place additional strain on...
10.
Lewis R, Billings C, Hurdman J, Smith I, Austin M, Armstrong I, et al.
Ann Am Thorac Soc
. 2020 Sep;
18(1):34-43.
PMID: 32926635
Exercise capacity predicts mortality in pulmonary arterial hypertension (PAH), but limited data exist on the routine use of maximal exercise testing. This study evaluates a simple-to-perform maximal test (the incremental...